Abstract: The present disclosure provides methods of treating brain injuries or conditions, or symptoms of brain injuries or conditions, including intranasal administration of a therapeutically effective amount of a taxane. The intranasally administered taxane can bypass the blood-brain barrier (BBB) via the olfactory epithelium and thereby provide therapeutic effect to a subject.

Abstract: A method for assessing a treatment in a trial includes obtaining images generated from image data acquired at different times during a trial time period for a same region of interest of a subject. The treatment is administered to the subject for the trial. The method further includes co-registering the images and mapping the co-registered images to a reference image representing the region of interest. The method further includes generating a trial image of the region of interest showing at least one of structural or functional physiological changes that occurred during the trial time period based on the mapped co-registered images, and displaying the trial image.

Abstract: Methods and apparatus for determining brain cortical thickness are provided. One method includes determining an intensity profile at each of a plurality of cortical surface points of an imaged brain using brain tissue image data and calculating a cortical thickness based on a parametrically determined transition point of each intensity profile.

Abstract: A method for assessing a treatment in a trial includes obtaining images generated from image data acquired at different times during a trial time period for a same region of interest of a subject. The treatment is administered to the subject for the trial. The method further includes co-registering the images and mapping the co-registered images to a reference image representing the region of interest. The method further includes generating a trial image of the region of interest showing at least one of structural or functional physiological changes that occurred during the trial time period based on the mapped co-registered images, and displaying the trial image.

Abstract: A method for assessing a treatment in a trial includes obtaining images generated from image data acquired at different times during a trial time period for a same region of interest of a subject. The treatment is administered to the subject for the trial. The method further includes co-registering the images and mapping the co-registered images to a reference image representing the region of interest. The method further includes generating a trial image of the region of interest showing at least one of structural or functional physiological changes that occurred during the trial time period based on the mapped co-registered images, and displaying the trial image.

Abstract: CPU 12 reads out the bloodstream associated values of target voxel of subject's standardized brain bloodstream images (step S34). CPU 12 sorts the bloodstream associated values in descending order (step S35). CPU 12 rejects bloodstream associated values that are ranked top 10% and bottom 40% (step S36). When the subjects are 20 for example, bloodstream associated values of highest 2 subjects and of lowest 8 subjects are rejected. CPU 12 calculates and stores mean value and standard deviation of remaining bloodstream associated values after the rejection (step S37). CPU 12 calculates mean value and standard deviation of bloodstream associated values for each voxel as target voxel (steps S31, S32, S33 and S38). Then, the alternative normal brain database of brain bloodstream image is obtained.

Abstract: CPU 12 reads out the bloodstream associated values of target voxel of subject's standardized brain bloodstream images (step S34). CPU 12 sorts the bloodstream associated values in descending order (step S35). CPU 12 rejects bloodstream associated values that are ranked top 10% and bottom 40% (step S36). When the subjects are 20 for example, bloodstream associated values of highest 2 subjects and of lowest 8 subjects are rejected. CPU 12 calculates and stores mean value and standard deviation of remaining bloodstream associated values after the rejection (step S37). CPU 12 calculates mean value and standard deviation of bloodstream associated values for each voxel as target voxel (steps S31, S32, S33 and S38). Then, the alternative normal brain database of brain bloodstream image is obtained.

Abstract: A method for assessing a treatment in a trial includes obtaining images generated from image data acquired at different times during a trial time period for a same region of interest of a subject. The treatment is administered to the subject for the trial. The method further includes co-registering the images and mapping the co-registered images to a reference image representing the region of interest. The method further includes generating a trial image of the region of interest showing at least one of structural or functional physiological changes that occurred during the trial time period based on the mapped co-registered images, and displaying the trial image.

Abstract: Methods and apparatus for determining brain cortical thickness. One method includes determining an intensity profile at each of a plurality of cortical surface points of an imaged brain using brain tissue image data and calculating a cortical thickness based on a parametrically determined transition point of each intensity profile.

Abstract: CPU 12 reads out the bloodstream associated values of target voxel of subject's standardized brain bloodstream images (step S34). CPU 12 sorts the bloodstream associated values in descending order (step S35). CPU 12 rejects bloodstream associated values that are ranked top 10% and bottom 40% (step S36). When the subjects are 20 for example, bloodstream associated values of highest 2 subjects and of lowest 8 subjects are rejected. CPU 12 calculates and stores mean value and standard deviation of remaining bloodstream associated values after the rejection (step S37). CPU 12 calculates mean value and standard deviation of bloodstream associated values for each voxel as target voxel (steps S31, S32, S33 and S38). Then, the alternative normal brain database of brain bloodstream image is obtained.

Abstract: Systems, methods and apparatus are provided through which in some embodiments, and database of images have categorized levels of severity of a disease or medical condition is generated from human designation of the severity. In some embodiments, the severity of a disease or medical condition is diagnosed by comparison of a patient image to images in the database. In some embodiments, changes in the severity of a disease or medical condition of a patient are measured by comparing a patient image to images in the database.

Abstract: Systems, methods and apparatus are provided through which in some embodiments, and database of images have categorized levels of severity of a disease or medical condition is generated from human designation of the severity. In some embodiments, the severity of a disease or medical condition is diagnosed by comparison of a patient image to images in the database. In some embodiments, changes in the severity of a disease or medical condition of a patient are measured by comparing a patient image to images in the database.

Abstract: Systems, methods and apparatus are provided through which in some embodiments, and database of images have categorized levels of severity of a disease or medical condition is generated from human designation of the severity. In some embodiments, the severity of a disease or medical condition is diagnosed by comparison of a patient image to images in the database. In some embodiments, changes in the severity of a disease or medical condition of a patient are measured by comparing a patient image to images in the database.

Abstract: Primaiy supernatant liquid collector 1 allows blood A to separate into a primary supernatant liquid B and red blood cells by leaving the blood A stationary for a prescribed period of time, and then it discharges the primary supernatant liquid B and physiological saline W in the same amount into a first treatment container 13 and a first balance container 14, respectively. Centrifuge 61 centrifuges the above primary supernatant liquid B using the first balance container 14 as a balance weight, and a secondary supernatant liquid in the first treatment container 13 is transferred to a second treatment container 109 by take-out device 91 and at the same time the physiological saline W in the same amount as the transferred secondary supernatant liquid is transferred from the first balance container 14 to a second balance container 110.

Abstract: A signal processing circuit for a magnetic recording/reproducing apparatus, including at least an AGC, a PLL, a LPF, an equalizer circuit and a detection circuit, wherein a coefficient compensation circuit is formed by defining a constitution of the equalizer circuit, an error detection circuit is provided which operates by receiving input from the detection circuit, and the LSI is formed by a plurality of analog and digital chips, and the analog and digital chips are connected by current-output type D/A converters connected to at least the AGC and the PLL.

Abstract: A signal processing circuit for a magnetic recording/reproducing apparatus, including at least an AGC, a PLL, a LPF, an equalizer circuit and a detection circuit, wherein a coefficient compensation circuit is formed by defining a constitution of the equalizer circuit, an error detection circuit is provided which operates by receiving input from the detection circuit, and the LSI is formed by a plurality of analog and digital chips, and the analog and digital chips are connected by current-output type D/A converters connected to at least the AGC and the PLL.

Abstract: Primary supernatant liquid collecting means 1 allows blood A to separate into a primary supernatant liquid B and red blood cells by leaving the blood A stationary for a prescribed period of time, and then it discharges the primary supernatant liquid B and physiological saline W in the same amount into a first treatment container 13 and a first balance container 14, respectively.

Abstract: A signal processing circuit for a magnetic recording/reproducing apparatus, including at least an AGC, a PLL, a LPF, an equalizer circuit and a detection circuit, wherein a coefficient compensation circuit is formed by defining a constitution of the equalizer circuit, an error detection circuit is provided which operates by receiving input from the detection circuit, and the LSI is formed by a plurality of analog and digital chips, and the analog and digital chips are connected by current-output type D/A converters connected to at least the AGC and the PLL.

Abstract: A signal processing circuit for a magnetic recording/reproducing apparatus, including at least an AGC, a PLL, a LPF, an equalizer circuit and a detection circuit, wherein a coefficient compensation circuit is formed by defining a constitution of the equalizer circuit, an error detection circuit is provided which operates by receiving input from the detection circuit, and the LSI is formed by a plurality of analog and digital chips, and the analog and digital chips are connected by current-output type D/A converters connected to at least the AGC and the PLL.

Abstract: A data reproducing circuit having a magnetic head for reading data from a recording medium, an adaptive equalization circuit for optimizing the waveform of a read signal, a discriminator circuit for discriminating an output signal of the adaptive equalization circuit and outputting a discriminated signal to an upper stage circuit, a format detecting circuit for detecting a pattern of signals written on the recording medium from outputs of the magnetic head, an expected value generating circuit for generating an expected value of the waveform of the read signal in accordance with an output of the adaptive equalization circuit and an output of the discriminator circuit, and an error detecting circuit for generating an error signal representing a difference between an output of the adaptive equalization circuit and an output of the expected value generating circuit.